Powder: -20°C for 3 years | In solvent: -80°C for 1 year
FMK 9a is an irreversible inhibitor of ATG4B with IC50 values of 80 and 73 nM in the TR-FRET and cellular-based LRA assays.
説明 | FMK 9a is an irreversible inhibitor of ATG4B with IC50 values of 80 and 73 nM in the TR-FRET and cellular-based LRA assays. |
ターゲット&IC50 | Autophagin-1 (FRET assay):80 nM, Autophagin-1 (LRA assay):73 nM |
In vitro | FMK 9a forms a covalent bond with the more reactive thiol group of Cys74 located at the catalytic site of ATG4B thereby inactivating ATG4B proteolytic activity[1]. |
In vivo | FMK 9a shows moderate solubility and high liver microsome clearances for human and mice of 13.9 and 70 mL/kg/min[1]. |
分子量 | 392.42 |
分子式 | C23H21FN2O3 |
CAS No. | 1955550-51-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 95 mg/mL (242.09 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
FMK 9a 1955550-51-2 Autophagy Proteases/Proteasome Cysteine Protease inhibit Inhibitor inhibitor